A partnership should not be dilutive to shareholders but, some kind of acquisition or merger could be painful. However it was stated on the last call that targets for a merge or acquisition have not panned out so maybe that doesn’t fly or maybe it is not seriously being considered any longer. If an acquisition/merger is out we might gain financial footing if they can partner with someone and as a result earn some grant money, or maybe grant money from the Inflation Reduction Act will come in. Regardless, grant money probably won’t fund the company 100% and they will soon run out of cash and have to fund raise again. This was a question I sent in for the last call but it was not addressed. So it seems there might not be an option where shareholders are not diluted unless the company begins earning revenue to operate on which looks to be a way off. There is nothing close to being ready for market unless it is CHS. But, we don’t really understand the reasons CHS isn’t already for sale making revenue as was expected in 2021.
Of the companies that I am familiar with, Amprius seems to be most similar to what I would like to see Coretec become. Amprius has a patented silicon anode battery which is actually for sale and on the market – who doesn’t want to see Coretec get to that level? Amprius has a current (declining) stock price of $5.80 with 84 million shares outstanding resulting in a market cap of 494 million dollars. Coretec’s current market cap is approximately 8.5 million and for Coretec to become equal in value to Amprius, we’d need a stock price north of $1.70!! But what is going to get us there? Revenue would go a long way to that end. BTW Amprius LOST 16.5 cents per share, their problem seems to be that even though they have a fine silicon anode battery design on the market, they lack manufacturing capacity. If I remember correctly they are trying to build this themselves, and recently registered a butt load of shares to sell. On the day that S-1 registration statement came out, the stock price bombed from 11 dollars down to 6 dollars. Seems to me that Amprius (like Coretec?) should be looking to partner with someone who HAS manufacturing capacity to build their cell and get them out there in volume (and make some money) even if it cuts into potential profit/margin.
I’ve rambled, curious what others think on this topic…
